Are you above the legal age to view this content in your province/state?

UNITED KINGDOM, October 9, 2019, (HEALTH EUROPA) - Zelda Therapeutics Limited has announced a proposed merger of equals with Ilera Therapeutics LLC (Ilera Therapeutics). Ilera Therapeutics is a privately held medical cannabis and cannabinoid science company based in the United States and, subject to approval from Zelda shareholders and all conditions of sale being met,...
U.S, July 9 2021 (ANALYTICALCANNABIS) It’s long been known that cannabis can impair a consumer’s memory and their ability to recall information. But in a new study, a group of researchers have found that, contrary to their predictions, high potency cannabis concentrates don’t seem to significantly...
U.S, MARIJUANA BUSINESS DAILY (20 June 21) Recreational marijuana makes the most headlines, but a large number of cannabis consumers buy and use the plant for medical and wellness reasons. These include acute medical conditions such as cancer, chronic pain and epilepsy, as well...
U.S, February 12, 2020 (CANNABISTECH) Solving bioavailability issues with cannabinoids, nanoemulsion technology and ultrasonic techniques increase product effectiveness. Cannabis has always had an issue with bioavailability. Whether smoked, eaten, or applied, each method of delivery loses a significant percentage of medicinal or...
U.S, December 21, 2019 (INDEPENDENT) Thousands of people with severe epilepsy will be able to access a cannabis-based treatment on the NHS from the new year, it has been revealed. Epidyolex, a cannabidiol (CBD) oral medication, has been fast-tracked by the health service in England to be available from 6...
U.S, November 27, 2019 (HEMPGAZETTE) A recent study out of Washington State University indicates inhaled cannabis may reduce the intensity of headaches and migraines. Led by Carrie Cuttler, a WSU assistant professor of psychology, a research term analyzed information submitted by more than 1,300 patients who used the Strainprint app...